[ Price : $8.95]
Federal Register notice: FDA announces a 5/12 Advisory Committee meeting to review a Sarepta Therapeutics BLA for a Duchenne muscu...[ Price : $8.95]
FDA grants Reach Neuro a breakthrough designation for its Avantis platform, which the company says uses small electrical impulses ...[ Price : $8.95]
The Department of Justice officially appeals Texas federal judge Matthew J. Kacsmaryks 4/7 controversial court order to undo FDAs ...[ Price : $8.95]
Merck and Eisai say they are discontinuing the Phase 3 LEAP-003 trial evaluating Keytruda plus Lenvima for first-line treatment of...[ Price : $8.95]
Horizon Therapeutics says it plans to discuss with FDA positive and statistically significant topline results from a Phase 4 clini...[ Price : $8.95]
FDA grants Sumitomo Pharma Oncology an Orphan Drug Designation for TP-1287, an investigational oral CDK9 inhibitor for treating Ew...[ Price : $8.95]
Philips recalls (Class1) certain reworked DreamStation breathing devices due to some devices being assigned incorrect or duplicate...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled Imports and Electronic Import Entries ...